[1P] F. Disorders of the Nervous System 2

[1P-232] Serum neurofilament light chain associated with outcome in Guillain-Barré syndrome across regions and disease spectrum

*Benjamin Hoehn¹, Zhahirul Islam², Kazim A. Sheikh³, Thomas Harbo⁴, Israt Jahan², Shoma Hayat², Henk-André Kroon¹, Ellen Cahir-McFarland¹, Ted Yednock¹, Sanjay Keswani¹, Quazi Deen Mohammad⁵ (1. Annexon Biosciences, Inc., Brisbane, CA, USA, 2. Laboratory of Gut-Brain Signaling, Laboratory Sciences and Services Division, icddr,b, Dhaka, Bangladesh, 3. Department of Neurology, McGovern Medical School, Houston, TX, USA, 4. Department of Neurology, Aarhus University Hospital, Aarhus, Denmark, 5. National Institute of Neurosciences and Hospital, Dhaka, Bangladesh)

Keywords:Guillain-Barré syndrome, neurofilament-light, prognostic biomarker, complement